From: Comprehensive molecular biomarker identification in breast cancer brain metastases
Category | BCBM vs. BCÂ intersecting with BCBM vs. prBT | BCBM shared with prBT | ||||
---|---|---|---|---|---|---|
p-value | Overlap (%) | Score | p-value | Overlap (%) | Score | |
Top canonical pathways | ||||||
Role of BRCA1 in DNA damage response | 1.04E−03 | 7.7 |  |  |  |  |
d-Myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis | 4.12E−03 | 5.1 |  |  |  |  |
d-Myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis | 4.12E−03 | 5.1 |  |  |  |  |
Estrogen-mediated S-phase entry | 5.13E−03 | 12.5 |  |  |  |  |
3-phosphoinositide degradation | 6.98E−03 | 4.7 |  |  |  |  |
EIF2 signaling |  |  |  | 3.20E−04 | 5.7 |  |
Systemic lupus erythematosus signaling |  |  |  | 6.10E−03 | 4.8 |  |
Oxidative phosphorylation |  |  |  | 7.43E−03 | 6.1 |  |
Superoxide radicals degradation |  |  |  | 7.94E−03 | 25.0 |  |
TNFR2 signaling |  |  |  | 1.25E−02 | 10.7 |  |
Top networks related to diseases and functions | ||||||
Cell cycle, DNA replication, recombination, and repair, cellular assembly and organization | Â | Â | 44 | Â | Â | Â |
Connective tissue disorders, developmental disorder, gastrointestinal disease | Â | Â | 39 | Â | Â | Â |
Cellular assembly and organization, inflammatory disease, inflammatory response | Â | Â | 37 | Â | Â | Â |
Cancer, cell death and survival, organismal injury and abnormalities | Â | Â | Â | Â | Â | 51 |
Hereditary disorder, neurological disease, organismal injury and abnormalities | Â | Â | Â | Â | Â | 48 |
Carbohydrate metabolism, drug metabolism, molecular transport | Â | Â | Â | Â | Â | 41 |